EUVIMEDEUVIMED entdecken
Fallbericht

Surgical resection and targeted therapy in a pediatric NTRK-rearranged low-grade spindle cell sarcoma: a case report

Chien-Kai Wang, Yen-Lin Liu, Wan-Ling Ho, Shu-Mei Chen

Child's Nervous System · 2025

DOI: 10.1007/s00381-025-07062-2 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Child's Nervous System, 2025. Verfasst von Chien-Kai Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Sarcoma, Receptor, trkA, Soft Tissue Neoplasms. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Neurotrophic tropomyosin receptor kinase (NTRK) gene fusions have emerged as important oncogenic drivers across a wide range of malignancies, including soft tissue sarcomas. Early detection of these fusions facilitates precision treatment with TRK inhibitors, significantly improving clinical outcomes. However, diagnosing NTRK-rearranged spindle cell neoplasms (NTRK-RSCNs) remains challenging due to their histological heterogeneity and overlap with other soft tissue tumors. CASE PRESENTATION: We present the case of an 8-year-old boy with a history of infantile fibromatosis, who developed progressive right ankle dorsiflexion weakness and right foot drop. Magnetic resonance imaging revealed a large, homogeneously enhancing soft tissue mass with extensive perineural involvement and spinal cord compression spread from T8 to L3 levels. The patient underwent T10-L1 laminectomy and partial tumor resection under intraoperative neurophysiological monitoring. DIAGNOSIS, TREATMENT, AND OUTCOME: Histopathological analysis identified a low-grade spindle cell neoplasm with focal positivity for S100 and CD34, and patchy pan-tropomyosin receptor kinase (TRK) expression. Molecular studies using fluorescence in situ hybridization and RNA-based next-generation sequencing confirmed a TPM3-NTRK1 fusion, establishing the diagnosis of NTRK-rearranged low-grade spindle cell sarcoma. Postoperatively, targeted therapy with a TRK inhibitor Larotrectinib (100 mg/m2/dose twice daily) was initiated. Over a 2-year follow-up period, the patient demonstrated significant neurological improvement and stable disease without evidence of progression on serial imaging studies. CONCLUSION: This case underscores the importance of integrating molecular diagnostics into the evaluation of atypical spindle cell tumors, particularly those presenting with aggressive clinical features despite low-grade histology. Early identification of NTRK fusions enables timely initiation of TRK inhibitor therapy, offering durable disease control and functional recovery. Broader awareness and implementation of molecular testing can greatly enhance the management of rare pediatric sarcomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaReceptor, trkASoft Tissue NeoplasmsHumansMaleChildPyrimidinesGene RearrangementPyrazolesMolecular Targeted Therapy

Stichwörter der Autor:innen

LarotrectinibNTRK fusionPediatric sarcomaSpinal tumorTargeted therapy

Substanzen

Receptor, trkAlarotrectinibPyrimidinesPyrazoles

Autor:innen und Institutionen

  • Department of Neurosurgery, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.
  • Taipei Neuroscience Institute, Taipei Medical University, Taipei, Taiwan.
  • Department of Pediatrics, Taipei Medical University Hospital, Taipei, Taiwan.
  • Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.
  • Department of Neurosurgery, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan. chen5319@tmu.edu.tw.

Zitieren

APA

Wang, C. K., Liu, Y. L., Ho, W. L., & Chen, S. M. (2025). Surgical resection and targeted therapy in a pediatric NTRK-rearranged low-grade spindle cell sarcoma: a case report. Child's Nervous System. https://doi.org/10.1007/s00381-025-07062-2

Vancouver

Wang CK, Liu YL, Ho WL, Chen SM. Surgical resection and targeted therapy in a pediatric NTRK-rearranged low-grade spindle cell sarcoma: a case report. Child's Nervous System. 2025. doi:10.1007/s00381-025-07062-2

BibTeX
@article{Wang2025,
  author = {Wang, Chien-Kai and Liu, Yen-Lin and Ho, Wan-Ling and Chen, Shu-Mei},
  title = {Surgical resection and targeted therapy in a pediatric NTRK-rearranged low-grade spindle cell sarcoma: a case report},
  journal = {Child's Nervous System},
  year = {2025},
  doi = {10.1007/s00381-025-07062-2}
}
Kostenlos starten →